TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board
China-based TenNor Therapeutics (Suzhou) Limited announced the submission of its listing application to the Main...
TenNor Therapeutics
TenNor Therapeutics Partners with Grand Life Sciences for Rifasutenizol Commercialization in China
China-based TenNor Therapeutics has entered into an exclusive commercialization cooperation agreement with compatriot firm Grand...
TenNor Therapeutics’ Rifasutenizol Shows High Eradication Rate in H. pylori Phase III Study
China-based TenNor Therapeutics has announced positive results from its Phase III clinical study for rifasutenizol...